Parasite | Eso | Sto | Cancer | ESD
001 | 101 | 201 | 301 | 401 | 501 | 601 | 701 | 801 | 901 | 1000
40´ë ³²¼º
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
¾Æ·¡·Î
70´ë ³²¼º¿¡¼ multiple EGC¿Í GISTÀÇ impressionÀ¸·Î ¼ö¼úÀ» ½ÃÇàÇÏ¿© ¾Æ·¡¿Í °°Àº °á°ú¸¦ ¾ò¾ú½À´Ï´Ù. ¼ö¼úÀü À§¾ÏÀº 3°³ÀÇ EGCÀÏ °ÍÀ¸·Î »ý°¢ÇÏ¿´À¸³ª ÀüÁ¤ºÎÀÇ 1¹ø º´¼Ò°¡ AGC·Î ³ª¿Ô½À´Ï´Ù. Áï EGC-mimicking AGCÀÔ´Ï´Ù (¾î¶² ºÐÀº AGC, mimicking EGC¶ó°íµµ ºÎ¸¨´Ï´Ù. ¿ë¾î°¡ ´Ù¼Ò È¥¶õ½º·¯¿ì¹Ç·Î ÁÖÀÇÇÏ¿© »ç¿ëÇϽñ⠹ٶø´Ï´Ù). ´ÙÇེ·´°Ô lymph node metastasis´Â ¾ø¾ú½À´Ï´Ù.
1. AGC (antrum), Borrmann type unclassifiable (mimicking EGC), signet ring cell carcinoma, 4.7 cm, extension to PM layer
2. EGC (prepyloric area), papillary adenocarcinoma (M/D), 2.4 cm, extension to lamina propria
3. EGC (midbody), tubular adenocarcinoma (M/D), 2.5 cm, extensiont to lamina propria
4. GIST of very low risk of aggressive behavior by new risk stratification, epithelioid (cellular epithelioid subtype), mitosis 0/50 HPF, 3 cm
2014. 6. 21. ÀÌÁØÇà